These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31558003)

  • 21. Dilute Russell's viper venom and activated partial thromboplastin time in lupus anticoagulant diagnosis: is mixing essential?
    Chandrashekar V
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):408-11. PubMed ID: 26626041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupus anticoagulant assay cut-offs vary between reagents even when derived from a common set of normal donor plasmas.
    Moore GW; Kumano O
    J Thromb Haemost; 2020 Feb; 18(2):439-444. PubMed ID: 31663664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients.
    Moore GW; Culhane AP; Maloney JC; Archer RA; Breen KA; Hunt BJ
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lupus anticoagulant mixing tests for multiple reagents are more sensitive if interpreted with a mixing test-specific cut-off than index of circulating anticoagulant.
    Kumano O; Moore GW
    Res Pract Thromb Haemost; 2018 Jan; 2(1):105-113. PubMed ID: 30046711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma.
    Moore GW; Kamat AV; Gurney DA; O'Connor O; Rangarajan S; Carr R; Savidge GF
    Clin Lab Haematol; 2004 Dec; 26(6):429-34. PubMed ID: 15596003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new-generation dilute Russell's viper venom time assay system for lupus anticoagulants: evaluation of detection utilising frozen reagents and controls.
    Moore GW; Tugnait S; Savidge GF
    Br J Biomed Sci; 2005; 62(3):127-32. PubMed ID: 16196459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
    Court EL
    Br J Biomed Sci; 1997 Dec; 54(4):287-98. PubMed ID: 9624740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ruling out lupus anticoagulants with mixing test-specific cutoff assessment and the index of circulating anticoagulant.
    Kumano O; Moore GW
    Res Pract Thromb Haemost; 2019 Oct; 3(4):695-703. PubMed ID: 31624789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixing studies for lupus anticoagulant: mostly no, sometimes yes.
    Moore GW
    Clin Chem Lab Med; 2020 Mar; 58(4):492-495. PubMed ID: 31874095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity.
    Simmons DP; Herskovits AZ; Battinelli EM; Schur PH; Lemire SJ; Dorfman DM
    Clin Chem Lab Med; 2018 Jul; 56(8):1289-1296. PubMed ID: 27305702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation.
    Devreese KMJ; de Groot PG; de Laat B; Erkan D; Favaloro EJ; Mackie I; Martinuzzo M; Ortel TL; Pengo V; Rand JH; Tripodi A; Wahl D; Cohen H
    J Thromb Haemost; 2020 Nov; 18(11):2828-2839. PubMed ID: 33462974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of mixing test-specific cut-off in lupus anticoagulant mixing test interpretation for multiple reagents.
    Kumano O; Moore GW
    Thromb Res; 2023 Nov; 231():39-43. PubMed ID: 37801773
    [No Abstract]   [Full Text] [Related]  

  • 33. Improved detection of lupus anticoagulants by the dilute Russell's Viper venom time.
    Moore GW; Savidge GF; Smith MP
    Blood Coagul Fibrinolysis; 2000 Dec; 11(8):767-74. PubMed ID: 11132656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy.
    Jouhikainen T
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):627-32. PubMed ID: 2133242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further evidence of false negative screening for lupus anticoagulants.
    Moore GW; Henley A; Greenwood CK; Rangarajan S
    Thromb Res; 2008; 121(4):477-84. PubMed ID: 17602725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell's viper venom time and silica clotting time increases thrombotic risk prediction.
    Lee Y; Gu JY; Kim HK
    J Thromb Thrombolysis; 2022 Aug; 54(2):318-322. PubMed ID: 35841477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of four coagulation tests to detect plasma lupus anticoagulants.
    Saxena R; Saraya AK; Kotte VK; Singh YN; Prasad L; Malviya AN
    Am J Clin Pathol; 1991 Dec; 96(6):755-8. PubMed ID: 1746492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid antibodies in children without and in adults with and without thrombophilia.
    Siemens HJ; Gutsche S; Brückner S; Bucsky P; Katus HA
    Thromb Res; 2000 May; 98(4):241-7. PubMed ID: 10822070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commonalities and contrasts in recent guidelines for lupus anticoagulant detection.
    Moore GW
    Int J Lab Hematol; 2014 Jun; 36(3):364-73. PubMed ID: 24750683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.